SlideShare une entreprise Scribd logo
1  sur  39
GLUCOSE TOLERANCE
TEST (GTT)
Main characteristics of T1DM and T2DM
T1DM T2DM
onset childhood adults
genetic disposition yes (oligogenic) yes (polygenic)
clinical manifestation often acute mild or none
autoimmunity yes No
insulin resistance no Yes
dependence on insulin yes No
obesity no yes
Clinical presentation of manifest DM
 due to the increase of
blood osmolality, osmotic
diuresis and
dehydratation
– classical
polyuria
thirst
polydipsia
weight loss
temporary impairment of visus
cutaneous infections
acute
hyperglycemic coma
ketoacidotic
non-ketoticidotic
Complications of DM
 microvascular
– diabetic retinopathy
– diabetic nephropathy
– diabetic neuropathy (sensoric, motoric, autonomic)
 macrovascular
– atherosclerosis (CAD, peripheral and cerebrovascular vascular
disease)
 combined
– diabetic foot (ulcerations, amputations and Charcot´s joint)
 others
– periodontitis
– cataract
– glaucoma
WHAT IS A GLUCOSE TOLERANCE TEST?
- It is a laboratory method to check how the body breaks
down (metabolizes) blood sugar, and how quickly it is
cleared from the blood.
- It is one of the tools used to diagnose prediabetes,
diabetes, insulin resistance and reactive hypoglycemia.
** 2 types of GTT:
a. Oral Glucose Tolerance Test (OGTT)
- ingestion of glucose solution in 5 minutes.
- most common form of GTT.
- fasting blood sugar (FBS) is measured
before ingestion.
b. Intravenous Glucose Tolerance Test (IGTT)
- glucose is injected into the vein for
three(3)
minutes.
- blood insulin levels are measured before
the injection.
- Most commonly done to check diabetes in:
* obese patients
* pregnant patients (as a screening test during the
24th – 28th weeks of pregnancy)
* patients with non-healing skin infections or
recurrent attacks of skin infections
* patients with family history of diabetes
PREPARATION AND PRECAUTIONS:
1. Do not restrict carbohydrate intake at least three (3)
days prior to the test.
(... balanced diet containing at least 150 – 200 gm
CHO/ day for three (3) days.)
2. Do not eat, drink, smoke or exercise strenuously for
at least 8 hours before the first blood sugar is taken.
3. All medications taken by the subject must be noted
and stopped, if possible, at least three(3) days prior
to the test.
PROCEDURE for OGTT:
1. The subject fasts for 10-14 hours or overnight.
2. Blood and urine samples are taken for analysis at
zero time (baseline).
3. The subject is then given a glucose solution to
drink.
He / She ingests 1 g/kg BW in 300 ml. It should be
drunk within 5 minutes.
4. Blood and urine samples are taken every 30 min
(after taking glucose solution) for three hours.
1999 WHO Diabetes criteria – Interpretation of Oral Glucose
Tolerance Test
Glucose
levels
NORMAL
Impaired Fasting
Glycaemia
Impaired Glucose
Tolerance
Diabetes
Mellitus
(I.F.G.) (I.G.T.) (D.M.)
Venous
Plasma
Fasting 2 hrs Fasting 2 hrs Fasting 2 hrs Fasting 2 hrs
(mmol/l) < 6.1 < 7.8 ≥6.1 & <7.0 <7.8 < 7.0 ≥ 7.8 ≥ 7.0 ≥11.
1
(mg/dl) < 110 < 140 ≥110 & <126 <140 < 126 ≥ 140 ≥ 126 ≥
200
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST

Contenu connexe

Tendances

Tendances (20)

Glucose Tolerance Test
Glucose Tolerance TestGlucose Tolerance Test
Glucose Tolerance Test
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Blood glucose testing
Blood glucose testingBlood glucose testing
Blood glucose testing
 
Analytical Methods of Diagnosing Diabetes Mellitus
Analytical Methods of Diagnosing Diabetes MellitusAnalytical Methods of Diagnosing Diabetes Mellitus
Analytical Methods of Diagnosing Diabetes Mellitus
 
Hemoglobin estimation
Hemoglobin  estimationHemoglobin  estimation
Hemoglobin estimation
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Glycosuria
GlycosuriaGlycosuria
Glycosuria
 
Glucose Tolerance Test Part-I.pptx
Glucose Tolerance Test Part-I.pptxGlucose Tolerance Test Part-I.pptx
Glucose Tolerance Test Part-I.pptx
 
Hba1 c
Hba1 cHba1 c
Hba1 c
 
Glucose Tolerance Test
Glucose Tolerance TestGlucose Tolerance Test
Glucose Tolerance Test
 
Glycogen storage disease (gsd)
Glycogen                  storage                    disease (gsd)Glycogen                  storage                    disease (gsd)
Glycogen storage disease (gsd)
 
Blood glucose test
Blood glucose testBlood glucose test
Blood glucose test
 
Estimation of serum triglycerides by Dr. Tehmas
Estimation of serum triglycerides by Dr. TehmasEstimation of serum triglycerides by Dr. Tehmas
Estimation of serum triglycerides by Dr. Tehmas
 
Blood glucose estimation
Blood glucose estimation Blood glucose estimation
Blood glucose estimation
 
Urine acetone
Urine acetoneUrine acetone
Urine acetone
 
Abnormal constituents of urine
Abnormal constituents of urineAbnormal constituents of urine
Abnormal constituents of urine
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
 
Diagnostic Tests of Diabetes
Diagnostic Tests of DiabetesDiagnostic Tests of Diabetes
Diagnostic Tests of Diabetes
 
Regulation blood glucose
Regulation blood glucoseRegulation blood glucose
Regulation blood glucose
 
Ketone bodies
Ketone bodiesKetone bodies
Ketone bodies
 

Similaire à GLUCOSE TOLERANCE TEST

Diabetes Mellitus management in OPD
Diabetes Mellitus management in OPDDiabetes Mellitus management in OPD
Diabetes Mellitus management in OPD
nium
 

Similaire à GLUCOSE TOLERANCE TEST (20)

Diabetes Mellitus, IFG, IGT & their diagnosis
Diabetes Mellitus, IFG, IGT & their diagnosisDiabetes Mellitus, IFG, IGT & their diagnosis
Diabetes Mellitus, IFG, IGT & their diagnosis
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Power point presentation on Type 2 Diabetes Mellitus
Power point presentation on Type 2 Diabetes MellitusPower point presentation on Type 2 Diabetes Mellitus
Power point presentation on Type 2 Diabetes Mellitus
 
Biochemistry-DISORDERS OF CARBOHYDRATE METABOLISM-1.ppt
Biochemistry-DISORDERS OF CARBOHYDRATE METABOLISM-1.pptBiochemistry-DISORDERS OF CARBOHYDRATE METABOLISM-1.ppt
Biochemistry-DISORDERS OF CARBOHYDRATE METABOLISM-1.ppt
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Dm 1 1
Dm 1 1Dm 1 1
Dm 1 1
 
Diabetes Mellitus management in OPD
Diabetes Mellitus management in OPDDiabetes Mellitus management in OPD
Diabetes Mellitus management in OPD
 
lab1 Glucose first.ppt
lab1 Glucose first.pptlab1 Glucose first.ppt
lab1 Glucose first.ppt
 
Diabetes mellitus management
Diabetes mellitus managementDiabetes mellitus management
Diabetes mellitus management
 
type 2 diabetes mellitus
type 2 diabetes mellitustype 2 diabetes mellitus
type 2 diabetes mellitus
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diab & managment.pptx
Diab & managment.pptxDiab & managment.pptx
Diab & managment.pptx
 
DIABETES MELLITUS AND Diabetes Ketoacidosis for ESR revision (002).pptx
DIABETES MELLITUS AND Diabetes Ketoacidosis for ESR revision (002).pptxDIABETES MELLITUS AND Diabetes Ketoacidosis for ESR revision (002).pptx
DIABETES MELLITUS AND Diabetes Ketoacidosis for ESR revision (002).pptx
 
Anti diabetic drugs
Anti diabetic drugsAnti diabetic drugs
Anti diabetic drugs
 
Presentation a bout diabetes
Presentation a bout diabetes   Presentation a bout diabetes
Presentation a bout diabetes
 
Diabetes.pdf
Diabetes.pdfDiabetes.pdf
Diabetes.pdf
 
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase MethodDetermination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
 
Dm
DmDm
Dm
 
Diabetes Mellitus - Medicine - ATOT
Diabetes Mellitus - Medicine - ATOTDiabetes Mellitus - Medicine - ATOT
Diabetes Mellitus - Medicine - ATOT
 
ENDOCRINE DISORDERS.pptx
ENDOCRINE DISORDERS.pptxENDOCRINE DISORDERS.pptx
ENDOCRINE DISORDERS.pptx
 

Plus de Dr Muhammad Mustansar

Plus de Dr Muhammad Mustansar (20)

students session
students sessionstudents session
students session
 
Lipid profile
Lipid profile Lipid profile
Lipid profile
 
Introduction of biochemistry
Introduction of  biochemistryIntroduction of  biochemistry
Introduction of biochemistry
 
BIOCHEMISTRY OF LIPIDS
BIOCHEMISTRY OF LIPIDSBIOCHEMISTRY OF LIPIDS
BIOCHEMISTRY OF LIPIDS
 
ECOSANOIDS
ECOSANOIDSECOSANOIDS
ECOSANOIDS
 
ROS ANTIOXIDENTS
ROS  ANTIOXIDENTSROS  ANTIOXIDENTS
ROS ANTIOXIDENTS
 
LIPID CHEMISTRY
LIPID CHEMISTRYLIPID CHEMISTRY
LIPID CHEMISTRY
 
Carcinogen
CarcinogenCarcinogen
Carcinogen
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 
Differences of plasma osmolarity
Differences of plasma osmolarityDifferences of plasma osmolarity
Differences of plasma osmolarity
 
Introdction of metabolism
Introdction of metabolismIntrodction of metabolism
Introdction of metabolism
 
TRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITIONTRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITION
 
TRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITIONTRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITION
 
Conference proceedings
Conference proceedings Conference proceedings
Conference proceedings
 
social media useage
social media useagesocial media useage
social media useage
 
DR MUHAMMAD MUSTANSAR
DR MUHAMMAD MUSTANSARDR MUHAMMAD MUSTANSAR
DR MUHAMMAD MUSTANSAR
 
STAINING TECHINIQUES
STAINING TECHINIQUESSTAINING TECHINIQUES
STAINING TECHINIQUES
 
Histopathology
HistopathologyHistopathology
Histopathology
 
Lactation
LactationLactation
Lactation
 
Biological oxidation
Biological oxidationBiological oxidation
Biological oxidation
 

Dernier

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Dernier (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Magic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptxMagic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Third Battle of Panipat detailed notes.pptx
Third Battle of Panipat detailed notes.pptxThird Battle of Panipat detailed notes.pptx
Third Battle of Panipat detailed notes.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 

GLUCOSE TOLERANCE TEST

  • 1.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. Main characteristics of T1DM and T2DM T1DM T2DM onset childhood adults genetic disposition yes (oligogenic) yes (polygenic) clinical manifestation often acute mild or none autoimmunity yes No insulin resistance no Yes dependence on insulin yes No obesity no yes
  • 13. Clinical presentation of manifest DM  due to the increase of blood osmolality, osmotic diuresis and dehydratation – classical polyuria thirst polydipsia weight loss temporary impairment of visus cutaneous infections acute hyperglycemic coma ketoacidotic non-ketoticidotic
  • 14. Complications of DM  microvascular – diabetic retinopathy – diabetic nephropathy – diabetic neuropathy (sensoric, motoric, autonomic)  macrovascular – atherosclerosis (CAD, peripheral and cerebrovascular vascular disease)  combined – diabetic foot (ulcerations, amputations and Charcot´s joint)  others – periodontitis – cataract – glaucoma
  • 15. WHAT IS A GLUCOSE TOLERANCE TEST? - It is a laboratory method to check how the body breaks down (metabolizes) blood sugar, and how quickly it is cleared from the blood. - It is one of the tools used to diagnose prediabetes, diabetes, insulin resistance and reactive hypoglycemia.
  • 16. ** 2 types of GTT: a. Oral Glucose Tolerance Test (OGTT) - ingestion of glucose solution in 5 minutes. - most common form of GTT. - fasting blood sugar (FBS) is measured before ingestion. b. Intravenous Glucose Tolerance Test (IGTT) - glucose is injected into the vein for three(3) minutes. - blood insulin levels are measured before the injection.
  • 17. - Most commonly done to check diabetes in: * obese patients * pregnant patients (as a screening test during the 24th – 28th weeks of pregnancy) * patients with non-healing skin infections or recurrent attacks of skin infections * patients with family history of diabetes
  • 18. PREPARATION AND PRECAUTIONS: 1. Do not restrict carbohydrate intake at least three (3) days prior to the test. (... balanced diet containing at least 150 – 200 gm CHO/ day for three (3) days.) 2. Do not eat, drink, smoke or exercise strenuously for at least 8 hours before the first blood sugar is taken. 3. All medications taken by the subject must be noted and stopped, if possible, at least three(3) days prior to the test.
  • 19. PROCEDURE for OGTT: 1. The subject fasts for 10-14 hours or overnight. 2. Blood and urine samples are taken for analysis at zero time (baseline). 3. The subject is then given a glucose solution to drink. He / She ingests 1 g/kg BW in 300 ml. It should be drunk within 5 minutes. 4. Blood and urine samples are taken every 30 min (after taking glucose solution) for three hours.
  • 20.
  • 21.
  • 22.
  • 23. 1999 WHO Diabetes criteria – Interpretation of Oral Glucose Tolerance Test Glucose levels NORMAL Impaired Fasting Glycaemia Impaired Glucose Tolerance Diabetes Mellitus (I.F.G.) (I.G.T.) (D.M.) Venous Plasma Fasting 2 hrs Fasting 2 hrs Fasting 2 hrs Fasting 2 hrs (mmol/l) < 6.1 < 7.8 ≥6.1 & <7.0 <7.8 < 7.0 ≥ 7.8 ≥ 7.0 ≥11. 1 (mg/dl) < 110 < 140 ≥110 & <126 <140 < 126 ≥ 140 ≥ 126 ≥ 200